Indiana University School of Medicine in Indianapolis has been awarded a $5.8 million Promise Grant from Susan G. Komen for the Cure as part of this year's allocation of $25.7 million for Promise Grants.
IU will try to establish biomarkers that doctors can use to better predict which breast cancer patients will benefit from the drug Avastin, and which cancer patients will suffer significant side effects from its use.
Promise Grants are large-scale grants (up to $7.5 million each during a five-year period) targeted to research that brings science to the bedside more quickly than ever before.
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment